• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦ EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Cardiology

Assessment of chest pain with CT angiography as effective as radionuclide imaging

byKenan Celtik, MSandSai Folmsbee
June 8, 2015
in Cardiology, Imaging and Intervention
Reading Time: 2 mins read
Assessment of chest pain with CT angiography as effective as radionuclide imaging
Share on FacebookShare on TwitterShare on LinkedIn

1. From a randomized trial of those with chest pain comparing coronary computed tomography angiography (CCTA) and myocardial perfusion imaging (MPI), there was no significant difference in the rate of revascularization.

2. There were no statistical differences between CCTA and MPI with regard to length of hospital stay, renal function, mortality, and cardiovascular events, but patients favored CCTA.

Evidence Rating Level: 1 (Excellent)

Study Rundown: Chest pain suspicious for coronary artery disease is a common reason for emergency room visits and hospitalizations. Evaluation of chest pain can include noninvasive cardiac imaging such as coronary computed tomography angiography (CCTA) and radionuclide stress myocardial perfusion imaging (MPI). To determine if noninvasive cardiac imaging could identify patients who would benefit from revascularization and to avoid catheterization in others, this single-center randomized study examined patients with chest pain, who were randomized to receive either CCTA or MPI. The primary outcome was catheterization not leading to percutaneous or surgical revascularization within one year. The results indicated that there were no significant differences between CCTA and MPI with regard to the primary outcome, median length of stay in hospital, change in kidney function, all-cause mortality, and nonfatal major cardiovascular events, like heart attack. However, those who received CCTA, compared to MPI, received a lower dose of radiation and felt more favorably toward it. The main limitation of this study was its small size, which may have limited its power.

Click to read the study, published today in the Annals of Internal Medicine

Relevant Reading: Clinical Research: Clinical Trial | May 2009 Coronary Computed Tomography Angiography for Early Triage of Patients With Acute Chest Pain

RELATED REPORTS

Patients with coronary artery disease have sustained elevation in blood pressure following exercise

Optical coherence tomography-guided angioplasty reduces adverse events compared to angiography guidance

In-Depth [randomized controlled trial]: A total of 400 patients were 1:1 randomized to receive CCTA or MPI. The patients were mean age 57 years, 63% women, 95% ethnic minority and mean BMI of 31. Thirty (15%) CCTA patients and 32 (16%) MPI patients had 1 or more catheterization within one year (p = 0.89). Among these patients, 15 CCTA and 20 MPI patients did not have revascularization (p = 0.44). The median time to catheterization and revascularization for CCTA patients was 3.5 days (IQR 2 – 28.5) and 2 days (IQR 1.5 – 3.5), respectively. For MPI, median time to catheterization and revascularization was 2 days (IQR 1 – 5) and 1.5 days (IQR 1 – 4), respectively. From a subgroup with significantly abnormal findings on imaging, 5 of 20 (25%) CCTA and 16 of 31 (52%) MPI had catheterization that did not lead to revascularization (absolute difference -27%, 95%CI -50% to -3.9%, p = 0.083). The difference in median subjective patient rating score (1 being the highest out of 10) was insignificant (p = 0.149) for CCTA and MPI, however a significantly greater proportion of patients rated MPI negatively with score of 5 or worse (p = 0.001).

Image: CC/Wiki

©2015 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: Coronary artery diseaserevascularization
Previous Post

Pediatric vesicoureteral reflux, bowel/bladder dysfunction increase recurrent UTI risk

Next Post

Statin medications linked to memory impairment

RelatedReports

Prevalence of hypertension among adolescents varies by race and BMI
Cardiology

Patients with coronary artery disease have sustained elevation in blood pressure following exercise

February 28, 2025
Drug-coated balloons are noninferior to drug-eluting stents for treatment of small vessel coronary artery disease
Cardiology

Optical coherence tomography-guided angioplasty reduces adverse events compared to angiography guidance

October 1, 2024
#VisualAbstract Edoxaban Monotherapy has Lower Risks for Atrial Fibrillation and Stable Coronary Artery Disease than Dual Antithrombotics
StudyGraphics

#VisualAbstract Edoxaban Monotherapy has Lower Risks for Atrial Fibrillation and Stable Coronary Artery Disease than Dual Antithrombotics

September 10, 2024
#VisualAbstract: Long-term Colchicine Does Not Reduce Recurrent Events Following Ischemic Stroke
StudyGraphics

#VisualAbstract: Long-term Colchicine Does Not Reduce Recurrent Events Following Ischemic Stroke

August 15, 2024
Next Post
Endostatin directly binds androgen receptors to treat prostate cancer [PreClinical]

Statin medications linked to memory impairment

2 Minute Medicine Rewind June 1 – June 7, 2015

2 Minute Medicine Rewind June 1 – June 7, 2015

Decline in adolescent sleep duration over past 20 years

Cognitive behavioral therapy effective for chronic insomnia

✦ EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

NPI Lookup · Free

Look up any US clinician

Search by name or NPI number, live from the CMS NPI Registry.

  • OIG exclusion check
  • Licenses and specialties
  • No account needed
Open NPI Lookup →

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Tarlatamab plus durvalumab improved survival versus durvalumab alone in extensive-stage small cell lung cancer, Amgen reports in interim phase 3 results
  • Sacituzumab tirumotecan improved overall survival versus platinum chemotherapy in company-reported final phase 3 results
  • Camupepimut did not improve disease-free survival versus observation in pancreatic cancer in the randomized phase 2 AMPLIFY-7P trial
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓NPI watchlist + bulk NPI verification

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.